Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

99mTc myocardial perfusion imaging.

S H Braat1

  • 1Academic Hospital of Maastricht, The Netherlands.

Current Opinion in Radiology
|December 1, 1991
PubMed
Summary

New technetium-99m tracers offer improved myocardial perfusion imaging compared to thallium-201. Agents like 99mTc-MIBI and 99mTc-teboroxime provide better physical characteristics and diagnostic capabilities for assessing heart conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Panic disorder in patients with chest pain and palpitations: an often unrecognized relationship].

Nederlands tijdschrift voor geneeskunde·2000
Same author

[Panic disorder, chest pain and palpitations: a pilot study of a Dutch First Heart Aid].

Nederlands tijdschrift voor geneeskunde·2000
Same author

Treatment of recent onset atrial fibrillation with intravenous sotalol and/or flecainide.

The Netherlands journal of medicine·1998
Same author

Serum lactate dehydrogenase activity: indicator of the development of pneumonitis induced by amiodarone.

European heart journal·1998
Same author

Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group.

Circulation·1995
Same author

Myocardial imaging with technetium-99m-tetrofosmin: comparison of one-day and two-day protocols.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1994

Area of Science:

  • Nuclear Cardiology
  • Radiopharmacology
  • Medical Imaging

Background:

  • Thallium-201 (201Tl) has limitations for myocardial perfusion and viability imaging due to suboptimal physical characteristics.
  • Technetium-99m (99mTc) based tracers, including isonitriles and BATO compounds, became available in the early 1990s.
  • These 99mTc tracers offer superior gamma photon energy and shorter half-life compared to 201Tl.

Purpose of the Study:

  • To evaluate the utility of new 99mTc tracers for myocardial perfusion and viability assessment.
  • To compare the imaging characteristics of 99mTc-MIBI and 99mTc-teboroxime with 201Tl.
  • To determine optimal protocols for utilizing these novel agents.

Main Methods:

  • Comparison of physical characteristics (photon energy, half-life) of 201Tl and 99mTc tracers.
  • Assessment of myocardial uptake, extraction fraction, and washout kinetics of 99mTc-MIBI and 99mTc-teboroxime.
  • Evaluation of the need for separate injections to differentiate ischemia from scar tissue.

Main Results:

  • 99mTc tracers exhibit improved physical properties over 201Tl for cardiac imaging.
  • 99mTc-hexakis-2-methoxyisobutyl isonitrile (MIBI) shows ideal characteristics for SPECT, with transient hepatic uptake and minimal redistribution.
  • 99mTc-teboroxime has a higher myocardial extraction fraction but rapid, flow-dependent washout, necessitating two injections for accurate diagnosis.

Conclusions:

  • New 99mTc tracers, particularly 99mTc-MIBI, represent advancements in myocardial perfusion imaging.
  • The lack of redistribution with 99mTc-MIBI and rapid washout of 99mTc-teboroxime require distinct injection protocols.
  • A 1-day protocol involving a rest study followed by an exercise study is recommended for these new agents.

Related Experiment Videos